Eating disorders are serious psychiatric conditions associated with significant medical and psychiatric morbidity and high mortality rates. Eating disorders affect all ethnic and racial groups and have been identified in all parts of the world, although prevalence rates vary for different populations. The purpose of this Clinical Update is to review some of the current issues relevant to identifying and treating eating disorders. Drs. Joanna Steinglass and Evelyn Attia will discuss the restrictive eating disorders including Anorexia Nervosa, and Avoidant-Restrictive Food Intake Disorder (ARFID) as well as emerging data about the importance of recognizing Atypical Anorexia Nervosa, one of the conditions included in the Other Specified Feeding and Eating Disorders in DSM5. Dr. B. Timothy Walsh will discuss Bulimia Nervosa and Binge Eating Disorder (BED), focusing on pharmacotherapy that has demonstrated efficacy for these conditions. The Clinical Update is intended for practitioners who see individuals with eating disorders in their clinical practice and are interested in new issues, and advanced discussion of treatment strategies. Program format will include time for audience Q & A.

Format

Recorded webinar, non-interactive, self-paced distance learning activity.

This presentation was recorded at the American Psychiatric Association Annual Meeting 2022.

Course References

• Walsh BT. The enigmatic persistence of anorexia nervosa. Am J Psychiatry. 2013. May;170(5):477-484.
• Attia E, Steinglass JE, Walsh BT, Wang Y, Wu P, Schreyer C, Wildes J, Yilmaz Z, Guarda AS, Kaplan AS, Marcus MD. Olanzapine versus Placebo in Adult Outpatients with Anorexia Nervosa: A Randomized Clinical Trial. Am J Psychiatry. 2019 Jun1;176(6):449-456.
• Crow SJ. Pharmacologic Treatment of Eating Disorders. Psychiatr Clin North Am. 2019 Jun;42(2):253-262.

Learning Objectives

• Recognize restrictive eating disorders and make initial treatment plans
• Understand recent developments in eating disorders treatment research including habit interruption, neuromoduation, and psychedelic agents.
• Know which medications are helpful for the treatment of binge eating episodes in bulimia nervosa and BED.

Target Audience

Psychiatrists

Estimated Time to Complete

Estimated Duration: 90 minutes
Begin Date: February 1, 2023
End Date: February 01, 2026

Physicians

 The APA designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty and Planner Disclosures

The American Psychiatric Association adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CME activity — including faculty, planners, reviewers or others — are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Program Presenters

• Evelyn Attia, MD, Director of the Center for Eating Disorders at New York-Presbyterian Hospital. Reports no financial relationships with commercial interests. 
• B. Walsh, MD. Reports no financial relationships with commercial interests. 
• Joanna Steinglass, MD, Professor of Psychiatry at Columbia University Irving Medical Center, Associate Director of the Eating Disorders Research Clinic at NYSPI/CUIMC. Reports no financial relationships with commercial interests. 
• Eric Williams, MD. Reports no financial relationships with commercial interests. 

Program Planners

• Jacqueline Maus Feldman, M.D., Chairperson, Scientific Program Committee, Reports no financial relationships with commercial interests.
• Robert O. Cotes, M.D., Vice-Chairperson, Scientific Program Committee, Reports no financial relationships with commercial interests. 
• Uchenna Okeye, M.D., Vice-Chairperson, Scientific Program Committee, Reports no financial relationships with commercial interests. 

Accessibility for Participants with Disabilities

The American Psychiatric Association is committed to ensuring accessibility of its website to people with disabilities. If you have trouble accessing any of APA’s online resources, please contact us at 202-559-3900 for assistance.

Technical Requirements

This internet-based CME activity is best experienced using any of the following:

• The latest and 2nd latest public versions of Google Chrome, Mozilla Firefox, or Safari
• Internet Explorer 11+

This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Acrobat Reader, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration:

• Browser: Google Chrome (latest and 2nd latest version), Safari (latest and 2nd latest version), Internet Explorer 11.0+, Firefox (latest and 2nd latest version), or Microsoft Edge (latest and 2nd latest version)
• Operating System: Windows versions 8.1+, Mac OS X 10.5 (Leopard) +, Android (latest and 2nd latest version), or iOS/iPad OS (latest and 2nd latest version)
• Internet Connection: 1 Mbps or higher

Minimum Requirements:

• Windows PC: Windows 8.1 or higher; 1 GB (for 32-bit)/2 GB (for 64-bit) or higher RAM; Microsoft DirectX 9 graphics device with WDDM driver; audio playback with speakers for programs with video content
• Macintosh: Mac OS X 10.5 or higher with latest updates installed; Intel, PowerPC G5, or PowerPC G4 (867MHz or faster) processor; 512 MB or higher RAM; audio playback with speakers for programs with video content

For assistance: Contact educme@psych.org for questions about this activity | Contact learningcenter@psych.org for technical assistance